ClinicalTrials.Veeva

Menu

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas

P

Peking University Cancer Hospital & Institute

Status

Enrolling

Conditions

PET/MRI

Study type

Observational

Funder types

Other

Identifiers

NCT05390632
XW-PET/CT &PET/MRI-001

Details and patient eligibility

About

Investigating the performance of 18F-FDG PET/CT and PET/MRI in lymphomas

Full description

In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the diagnosis of lymph node (LN) and organ involvement.

Enrollment

100 estimated patients

Sex

All

Ages

15 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pathologically diagnosed as lymphoma; Written informed consent for receiving PET/MRI after PET/CT examinations. cancer planned chemotherapy or immunotherapy scheme. expected survival ≥ 12 weeks

Exclusion criteria

  • cannot lie supine for half an hour; refuse to join the clinical researcher; severe liver or kidney dysfunction pregnancy or lactation

Trial contacts and locations

1

Loading...

Central trial contact

Zhi Yang, PhD; Xuejuan Wang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems